Health Catalyst achieved strong performance in Q4 2024, with total revenue reaching $79.6 million and Adjusted EBITDA at $7.9 million, significantly exceeding the previous year's figures. The Technology segment showed notable growth, contributing to the overall positive results.
Total revenue for Q4 2024 increased by 6% year-over-year to $79.6 million.
Adjusted EBITDA for Q4 2024 saw a substantial increase of 485% year-over-year, reaching $7.9 million.
The Technology segment's revenue for Q4 2024 was $51.6 million, contributing significantly to overall revenue.
Net loss for Q4 2024 improved to -$20.7 million from -$30.3 million in the prior year.
Health Catalyst provided optimistic forward-looking guidance for Q1 and the full year 2025, anticipating continued revenue growth and increased Adjusted EBITDA.
Visualization of income flow from segment revenue to net income